Implicaciones hepáticas en la pandemia por COVID-19

León Gómez, Janita; Gómez Aldana, Andrés José; Tapias, Mónica.
Rev. colomb. gastroenterol ; 35(supl.1)2020.
Artículo en Español | LILACS | ID: biblio-1096968

Documentos relacionados

  1. Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
  2. Assessing the mechanisms and adjunctive therapy for arsenic-induced liver injury in rats.
  3. Preparation of Active Peptides from <i>Camellia vietnamensis</i> and Their Metabolic Effects in Alcohol-Induced Liver Injury Cells.
  4. IP<sub>3</sub>R1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin.
  5. Characterization of Immature Myofibroblasts of Stellate Cell or Mesenchymal Cell Origin in D-Galactosamine-Induced Liver Injury in Rats.
  6. [Ligandrol-induced liver injury - Case Report].
  7. Zanubrutinib-induced liver injury: a case report and literature review.
  8. Hepatic CYP2B10 is highly induced by binge ethanol and contributes to acute-on-chronic alcohol-induced liver injury.
  9. GPR116 promotes ferroptosis in sepsis-induced liver injury by suppressing system Xc<sup>-</sup>/GSH/GPX4.
  10. Corticosteroid-Induced Liver Injury in Adult-Onset Still's Disease.